Sahil Kirpekar's most recent trade in ATAI Life Sciences N.V. was a trade of 48,563 Common Shares done at an average price of $1.3 . Disclosure was reported to the exchange on March 21, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
ATAI Life Sciences N.V. | Sahil Kirpekar | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 1.35 per share. | 21 Mar 2025 | 48,563 | 115,636 | - | 1.3 | 65,560 | Common Shares |
ATAI Life Sciences N.V. | Sahil Kirpekar | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 100,000 | 0 | - | - | Common Shares | |
ATAI Life Sciences N.V. | Sahil Kirpekar | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 100,000 | 164,199 | - | - | Common Shares | |
ATAI Life Sciences N.V. | Sahil Kirpekar | Chief Business Officer | 02 Apr 2024 | 35,801 | 64,199 | - | 1.9 | 66,232 | Common Shares | |
ATAI Life Sciences N.V. | Sahil Kirpekar | Chief Business Officer | 13 Mar 2024 | 550,000 | 550,000 | - | - | Stock Option | ||
ATAI Life Sciences N.V. | Sahil Kirpekar | Chief Business Officer | 13 Mar 2024 | 100,000 | 100,000 | - | - | Restricted Stock Units | ||
ATAI Life Sciences N.V. | Sahil Kirpekar | Chief Business Officer | 13 Mar 2024 | 100,000 | 100,000 | - | - | Common Shares | ||
ATAI Life Sciences N.V. | Sahil Kirpekar | Chief Business Officer | 14 Mar 2023 | 275,000 | 275,000 | - | - | Stock Option | ||
ATAI Life Sciences N.V. | Sahil Kirpekar | Chief Business Officer | 14 Mar 2023 | 200,000 | 200,000 | - | - | Restricted Stock Unit | ||
ATAI Life Sciences N.V. | Sahil Kirpekar | Chief Business Officer | 01 Dec 2022 | 750,000 | 750,000 | - | - | Stock Option |